HomeCompareRENB vs QSR

RENB vs QSR: Dividend Comparison 2026

RENB yields 140.85% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RENB wins by $18.20M in total portfolio value
10 years
RENB
RENB
● Live price
140.85%
Share price
$1.42
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.23M
Annual income
$7,605,007.88
Full RENB calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.90
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$386.99
Full QSR calculator →

Portfolio growth — RENB vs QSR

📍 RENB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRENBQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RENB + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RENB pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RENB
Annual income on $10K today (after 15% tax)
$11,971.83/yr
After 10yr DRIP, annual income (after tax)
$6,464,256.70/yr
QSR
Annual income on $10K today (after 15% tax)
$288.70/yr
After 10yr DRIP, annual income (after tax)
$328.94/yr
At 15% tax rate, RENB beats the other by $6,463,927.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RENB + QSR for your $10,000?

RENB: 50%QSR: 50%
100% QSR50/50100% RENB
Portfolio after 10yr
$9.13M
Annual income
$3,802,697.43/yr
Blended yield
41.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

RENB
No analyst data
Altman Z
-174.5
Piotroski
3/9
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.4% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RENB buys
0
QSR buys
0
No recent congressional trades found for RENB or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRENBQSR
Forward yield140.85%3.40%
Annual dividend / share$2.00$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$18.23M$24.7K
Annual income after 10y$7,605,007.88$386.99
Total dividends collected$16.79M$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock

Year-by-year: RENB vs QSR ($10,000, DRIP)

YearRENB PortfolioRENB Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$24,785$14,084.51$11,037$336.93+$13.7KRENB
2$59,143$32,624.07$12,154$344.76+$47.0KRENB
3$136,042$72,758.05$13,357$351.99+$122.7KRENB
4$301,974$156,409.10$14,651$358.62+$287.3KRENB
5$647,582$324,470.73$16,041$364.68+$631.5KRENB
6$1,343,219$650,306.15$17,534$370.18+$1.33MRENB
7$2,697,870$1,260,625.08$19,136$375.14+$2.68MRENB
8$5,253,056$2,366,334.87$20,856$379.58+$5.23MRENB
9$9,926,863$4,306,093.23$22,699$383.52+$9.90MRENB
10$18,226,751$7,605,007.88$24,675$386.99+$18.20MRENB

RENB vs QSR: Complete Analysis 2026

RENBStock

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Full RENB Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this RENB vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RENB vs SCHDRENB vs JEPIRENB vs ORENB vs KORENB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.